However, companies have taken definite measures to overcome such challenges. According to a study “Histopathology during the COVID-19 pandemic: resilience through adaptation and innovation” published in December 2020, carrying tissue samples between pathologist homes and hospitals and providing access to a microscope, and IT system to the pathologist place were some of the logistics challenges faced due to COVID-19 situations. The COVID-19 pandemic has affected the histology equipment market since its starting by facing a decline in the demand for the slide staining system and tissue processing system, as the clinical testing providers had to reallocate assets and staff to focus on the conduction of COVID-19 diagnostic tests.
